Coming up at #ASCO24 | Dr. Robert Smith from American Cancer Society is a panelist for the #MCED case-based panel session. Revisit his editorial co-authored with Fiona Walter & other experts that comments on prior modeling efforts for MCEDs. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert ACS Research

Hello, #ASCO24 . Find us at Exhibit Booth # 11031, and we also have ribbons for our ACS funded researchers!

Our Editorial Board Member and #ASCO24 Education Chair Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO will be moderating today's ASCO Voices session, highlighting personal stories and narratives shared by members of the oncology community. Join the session today at 1pm CT at s100a in McCormick Place. @Oncoalert

Our Medical Oncology Section Editor Dr. Cathy Eng participates in today's 'New Drugs in Oncology: Incorporation Into Practice' session at #ASCO24 . She'll be presenting on fruquintinib in refractory metastatic #ColorectalCancer at 1:10pm CT in the Arie Crown Theater. OncoAlert

Congratulations to Smita Bhatia of O'Neal Comprehensive Cancer Center at UAB, who receives the ASCO American Cancer Society #CancerPrevention Award today! Dr Bhatia served as our Section Editor for Outcomes Research and Survivorship for over 13 years (2008-2021). Well deserved, Dr Bhatia! OncoAlert #ASCO24

New American Cancer Society report finds that LGBTQ+ people face barriers to high-quality health care, including discrimination & shortfalls in provider knowledge of their unique medical needs.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

@oncoalert ACSNews Bill Dahut, MD Karen Knudsen, MBA PhD Natl LGBT Cancer Net #ASCO24

Older pts with AML who underwent SCT after low-intensity Rx on the Phase 2 trial of Ven+CLAD+LDAC alt with Ven+Aza had promising RFS/OS comparable to older pts who had SCT after INT therapy.

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@JayastuMD Hagop Kantarjian,MD Tapan Kadia OncoAlert #ASCO24

New & available #OpenAccess | The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert

Did you know that we have a new podcast? 🎙️ CancerSpeak is focused on sharing expert perspectives and patient experiences on emerging topics in clinical oncology, w/ convos tying back to articles published in Cancer. #ASCO24 Suresh S. Ramalingam, MD, FASCO OncoAlert
cancerspeak.podbean.com

Ponatinib induces high cytogenetic and molecular responses in frontline CML-CP. However, adverse events hinder its use in the frontline setting:
Fadi Haddad, MD MD Anderson Cancer Center #Leukemia
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… ACS Journal Cancer
#leusm #CML

In partnership w/ OncoAlert for #ASCO24 , we are excited to highlight new research from Fadi Haddad, MD et al on #Ponatinib as a frontline therapy for patients w/ #CML in chronic phase.

Hear from Dr Haddad below & access the article: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10… Hagop Kantarjian,MD #leusm

Published just ahead of #ASCO24 | Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert

Read our June 15 issue! 📗

acsjournals.onlinelibrary.wiley.com/toc/10970142/2…

✅ Northwestern Feinberg School of Medicine perspectives on #LungCancer biomarker testing
✅ Likhitha Kolla Ravi B. Parikh on uses & limitations for #AI in oncology
✅ Kassem S Faraj et al on the 340B program & adv #ProstateCancer

OncoAlert #ASCO24

Quality of control arms in randomized clinical trial implies also optimal postprotocol treatment. Read the latest editorial from Massimo Di Maio. OncoAlert acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Discover the latest trends in cancer incidence and mortality in the 2024 American Cancer Society annual cancer statistics report ahead of #ASCO24 . New data reveals that 4.1 million deaths from cancer have been averted since 1991.

Find more stats at: acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

OncoAlert

Timely work from Kassem S Faraj et al on #FinancialToxicity ahead of #ASCO24

'Addressing financial toxicity in cancer treatment—An opportunity for the 340B drug pricing program' acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@oncoalert Vivek Subbiah, MD

📣 Join us Sunday at 4pm CT for an #ASCO24 Meet and Greet with 3 of our Editors! Speak w/ @walterstadler5 & Dr Daniel Morgensztern of Washington U. Med about submitting your research to Cancer & discuss promotional ideas for your published work w/ #SoMe Editor Gil Morgan, MD. OncoAlert

Findings from a new Dana-Farber study show that approx. 1/3 of adult survivors of #ChildhoodCancer report clinically significant #SexualDysfunction , which underscores a significant screening & treatment need.

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Lydia Chevalier, PhD OncoAlert SaroArmenian

Just published | Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert #PCSM

A regional mailed FIT intervention was effective for increasing #ColorectalCancer screening rates across community health center systems serving diverse, low-income populations.

New study from Elena Martinez of UCSD Health Moores Cancer Center COE et al: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

OncoAlert #CRCSM